VNA
IONS icon

Valley National Advisers’s Ionis Pharmaceuticals IONS Stock Holding History

Valley National Advisers’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-11
Closed -$1K – 1091
2023
Q2 		$1K Hold
11
– – ﹤0.01% 893
2023
Q1 		$0 Hold
11
– – ﹤0.01% 930
2022
Q4 		$0 Hold
11
– – ﹤0.01% 909
2022
Q3 		$1K Hold
11
– – ﹤0.01% 844
2022
Q2 		$0 Hold
11
– – ﹤0.01% 933
2022
Q1 		$0 Hold
11
– – ﹤0.01% 949
2021
Q4 		$0 Buy
+11
New +$346 ﹤0.01% 940

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return

Valley National Advisers's IONS Position: Q3 2023 in Review

Valley National Advisers sold out of Ionis Pharmaceuticals (IONS) in Q3 2023, closing a stake of 11 shares — an estimated $1K sold.

Valley National Advisers first reported a position in IONS in Q4 2021 and held it in 7 quarters. The position peaked at $1K in Q2 2023. 310 funds tracked by Wall St. Rank hold IONS as of Q3 2023.

  • Valley National Advisers reported no remaining Ionis Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Valley National Advisers sold 11 Ionis Pharmaceuticals shares in Q3 2023, an estimated $1K.
  • Valley National Advisers first reported a position in Ionis Pharmaceuticals in Q4 2021 and held it in 7 quarters.
  • Valley National Advisers's Ionis Pharmaceuticals position peaked at $1K in Q2 2023.
  • 310 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2023.

Based on Valley National Advisers's 13F filing for Q3 2023, filed 13 Nov 2023.